Fresh Frozen Plasma (FFP) Dose Reference Calculator

About the Fresh Frozen Plasma (FFP) Dose Reference Calculator

Fresh frozen plasma (FFP) is a blood product containing all coagulation factors, fibrinogen, and plasma proteins. It is prepared from whole blood donations and stored at -18°C or colder, maintaining coagulation factor activity for up to one year. FFP is commonly discussed when multiple factor deficiencies are present, when vitamin K antagonist reversal is being reviewed and prothrombin complex concentrate is unavailable, and as replacement fluid during therapeutic plasma exchange.

Standard FFP dosing ranges from 10 to 20 mL/kg depending on the scenario being reviewed and the severity of coagulopathy. Each unit of FFP is approximately 200–300 mL (typically ~250 mL) and contains roughly 1 unit/mL of each coagulation factor. At a dose of 10–15 mL/kg, FFP may raise coagulation factor levels by approximately 15–25%. Higher doses of 15–20 mL/kg may be considered in severe bleeding or vitamin K antagonist reversal discussions, while balanced-product transfusion strategies vary by pathway.

This worksheet computes a reference volume and number of units based on patient weight and scenario, estimates the expected rise in coagulation factor levels, projects post-transfusion INR correction, and provides infusion-time context. It includes reference ranges for major FFP review contexts including bleeding, vitamin K antagonist reversal review, plasma exchange, liver disease, and balanced transfusion review.

When This Page Helps

Calculating FFP reference volumes by weight, converting to units, and estimating INR correction involves several steps that are easy to miscalculate under time pressure. This calculator keeps the arithmetic, unit rounding, and indication-based reference ranges together so the transfusion review can be cross-checked quickly.

How to Use the Inputs

1. Enter the patient's body weight in kg or lb, or select a weight preset.
2. Choose the clinical indication for FFP transfusion from the dropdown.
3. Enter the current INR value if available for INR correction estimation.
4. Enter the patient's hematocrit if known for more accurate plasma volume estimation.
5. Adjust the FFP unit volume if your blood bank uses non-standard unit sizes.
6. Review the calculated reference dose, number of units, and estimated correction.

Example Calculation

Tips & Best Practices

• Thawing time and usable post-thaw windows vary by blood-bank workflow, so check local handling details before relying on the timing estimate.
• Post-transfusion INR/PT review is often used to judge whether the reference dose was enough, but timing varies by the pathway in use.
• Balanced-product massive-transfusion strategies differ by center, so treat the table as context rather than as a stand-alone protocol.
• Desired INR thresholds vary by bleeding site and procedure type.
• FFP does not directly correct thrombocytopenia or low fibrinogen, so those issues usually require separate review.

FFP Composition and Storage

Each unit of FFP contains all coagulation factors at approximately 1 IU/mL, including Factors II, V, VII, VIII, IX, X, XI, XII, XIII, von Willebrand factor, fibrinogen (2–4 mg/mL), protein C, protein S, and antithrombin. FFP is stored at -18°C or below and has a shelf life of 12 months. Once thawed, it should be used within 24 hours (as "thawed plasma") or within 5 days if relabeled and stored at 1–6°C, though Factor V and Factor VIII activity decline significantly after thawing.

Indications and Evidence

Common evidence-supported FFP uses include (1) vitamin K antagonist reversal when PCC is unavailable, (2) correction of multiple clotting factor deficiencies with active bleeding, (3) replacement fluid in therapeutic plasma exchange for TTP, and (4) balanced transfusion support. The use of FFP to correct mildly elevated INR (< 1.8) without bleeding is controversial and generally not recommended, as the coagulation factor content of FFP may be insufficient to normalize INR from near-normal levels.

Alternatives to FFP

Four-factor PCC (Kcentra, Beriplex) has largely replaced FFP for urgent warfarin reversal in hospitals where it is available. PCC contains concentrated Factors II, VII, IX, and X with protein C and S, and provides faster, more predictable INR correction in much smaller volumes (typically 25–50 mL vs. 1,000+ mL for FFP). Cryoprecipitate is preferred when fibrinogen replacement is the primary goal. Recombinant Factor VIIa may be used for specific refractory hemorrhage scenarios but is expensive and carries thrombotic risk.

Frequently Asked Questions

• What is the standard FFP dose?

  A common reference range is 10–15 mL/kg for many scenarios. Higher volumes may be reviewed in vitamin K antagonist reversal or more severe bleeding contexts, while plasma exchange uses a different plasma-volume framework. Each unit is approximately 250 mL.

• How quickly should FFP be infused?

  Infusion timing depends on urgency, line access, patient tolerance, and blood-bank workflow. The timing on this page is only a reference estimate and should not replace the transfusion plan being used.

• Does FFP need to be ABO-compatible?

  Yes, FFP should be ABO-compatible. Group AB plasma is the universal donor plasma since it contains no anti-A or anti-B antibodies. Group-specific plasma is preferred when available. Rh compatibility is not required for FFP.

• When might 4-factor PCC be discussed instead of FFP?

  Four-factor prothrombin complex concentrate (PCC) is often discussed for urgent warfarin reversal because it can provide faster INR correction in smaller volumes. The choice still depends on urgency, availability, bleeding context, and the protocol being used.

• How long does FFP correction last?

  The duration of FFP effect depends on the half-lives of the replaced coagulation factors. Factor VII has the shortest half-life (~6 hours), so INR may begin rising again within 6–12 hours. Repeat dosing or addressing the underlying cause is often necessary.

• What are the risks of FFP transfusion?

  Risks include transfusion-related acute lung injury (TRALI), transfusion-associated circulatory overload (TACO), allergic reactions, febrile non-hemolytic reactions, and rarely infection transmission. Volume overload is a particular concern — 4 units of FFP add approximately 1 liter of volume.